The Technical Analyst
Select Language :
Assertio Holdings Inc [ASRT]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Assertio Holdings Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Assertio Holdings Inc is listed at the  Exchange

-3.10% $0.959

America/New_York / 28 mar 2024 @ 16:00


Assertio Holdings Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 91.13 mill
EPS: -4.67
P/E: -0.210
Earnings Date: May 06, 2024
SharesOutstanding: 95.00 mill
Avg Daily Volume: 1.118 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.210 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.210 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.907 - 1.011

( +/- 5.42%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-14 Tyree James L Sell 10 251 Common Stock
2024-02-21 Schlessinger Sam Buy 17 151 Common Stock
2024-02-21 Schlessinger Sam Sell 8 506 Common Stock
2024-02-21 Schlessinger Sam Sell 17 151 Restricted Stock Units
2024-02-21 Schwichtenberg Paul Buy 17 151 Common Stock
INSIDER POWER
24.77
Last 98 transactions
Buy: 4 490 251 | Sell: 3 123 118

Forecast: 16:00 - $0.959

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.959
Forecast 2: 16:00 - $0.959
Forecast 3: 16:00 - $0.959
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.959 (-3.10% )
Volume 0.931 mill
Avg. Vol. 1.118 mill
% of Avg. Vol 83.23 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Assertio Holdings Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Assertio Holdings Inc

RSI

Intraday RSI14 chart for Assertio Holdings Inc

Last 10 Buy & Sell Signals For ASRT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:32sell$0.793N/AActive
Profile picture for
            Assertio Holdings Inc

ASRT

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Last 10 Buy Signals

Date Signal @
LTCUSDMar 29 - 00:53$94.20
SNXUSDMar 29 - 00:51$4.99
FTMUSDMar 29 - 00:51$0.995
BATUSDMar 29 - 00:47$0.330
AUCTIONUSDMar 29 - 00:4625.08
GRSUSDMar 29 - 00:44$0.716
PROPCUSDMar 29 - 00:395.17
TUSDUSDMar 29 - 00:35$0.996
UQCUSDMar 29 - 00:34$9.10
USDTUSDMar 29 - 00:27$1.000

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.